Published in Vaccine Weekly, February 9th, 2000
The Bernhard-Nocht-Institute, based in Hamburg, Germany, and affiliated with the University of Hamburg, is conducting studies to evaluate the efficacy of combining their novel formulations of DNA vaccines with the INJEX needle-free injection system.
DNA-based immunizations may become an attractive alternative to traditional vaccines in the future. Instead of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.